These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9604875)

  • 1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
    Ng TF; Lee FK; Song ZT; Calcutt NA; Lee AY; Chung SS; Chung SK
    Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
    Whiteley SJ; Tomlinson DR
    Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
    Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
    Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats.
    Shinohara R; Mano T; Nagasaka A; Sawai Y; Uchimura K; Hayashi R; Hayakawa N; Nagata M; Makino M; Kakizawa H; Itoh Y; Nakai A; Itoh M
    Biochim Biophys Acta; 1998 Nov; 1425(3):577-86. PubMed ID: 9838221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.
    Matsumoto T; Ono Y; Kurono M; Kuromiya A; Nakamura K; Bril V
    J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant mRNA splicing causes sorbitol dehydrogenase deficiency in C57BL/LiA mice.
    Lee FK; Chung SK; Chung SS
    Genomics; 1997 Nov; 46(1):86-92. PubMed ID: 9403062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats.
    Hoshi A; Takahashi M; Fujii J; Myint T; Kaneto H; Suzuki K; Yamasaki Y; Kamada T; Taniguchi N
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):119-23. PubMed ID: 8761460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR; Robinson JP; Compton AM; Keen P
    Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
    Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
    Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glucose, sorbitol and fructose accumulation in lens and liver of diabetic and insulin-treated rats and mice.
    Gaynes BI; Watkins JB
    Comp Biochem Physiol B; 1989; 92(4):685-90. PubMed ID: 2498032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats.
    Orosz SE; Townsend SF; Tornheim PA; Brownscheidle CM
    Acta Diabetol Lat; 1981; 18(4):373-81. PubMed ID: 6800175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
    Collins JG; Corder CN
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
    Chan AW; Ho YS; Chung SK; Chung SS
    Exp Eye Res; 2008 Nov; 87(5):454-61. PubMed ID: 18760274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.